AI assistant
Nagarro SE — Interim / Quarterly Report 2025
Nov 14, 2025
719_rns_2025-11-14_2e5632a1-6a3e-424f-8f1b-9e70c3ce28a3.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
{0}------------------------------------------------

{1}------------------------------------------------
2
Nagarro Group
Key figures – Quarterly
| Q3 | Q3 | Q2 | |||
|---|---|---|---|---|---|
| 2025 | 2024 | Change | 2025 | Change | |
| kEUR | kEUR | % | kEUR | % | |
| Revenue | 254,569 | 242,925 | 4.8% | 251,976 | 1.0% |
| Cost of revenues | 170,368 | 166,454 | 2.4% | 168,266 | 1.2% |
| Gross profit | 84,208 | 76,544 | 10.0% | 83,740 | 0.6% |
| Adjusted EBITDA | 44,035 | 34,622 | 27.2% | 30,536 | 44.2% |
| Revenue by geography | |||||
| North America | 88,383 | 87,748 | 0.7% | 86,747 | 1.9% |
| Central Europe | 76,203 | 68,671 | 11.0% | 75,642 | 0.7% |
| Rest of Europe | 31,750 | 29,368 | 8.1% | 33,304 | -4.7% |
| Rest of World | 58,232 | 57,138 | 1.9% | 56,283 | 3.5% |
| Revenue by countryGermany | 59,716 | 52,889 | 12.9% | 59,421 | 0.5% |
| US | 88,117 | 86,919 | 1.4% | 86,253 | 2.2% |
| Revenue by industry | |||||
| Automotive, Manufacturing and Industrial | 65,038 | 54,699 | 18.9% | 62,562 | 4.0% |
| Energy, Utilities and Building Automation | 15,430 | 18,978 | -18.7% | 17,667 | -12.7% |
| Financial Services and Insurance | 32,424 | 31,436 | 3.1% | 31,111 | 4.2% |
| Horizontal Tech | 12,933 | 13,759 | -6.0% | 13,056 | -0.9% |
| Life Sciences and Healthcare | 18,105 | 16,240 | 11.5% | 18,103 | 0.0% |
| Management Consulting and Business Information | 20,233 | 15,551 | 30.1% | 19,337 | 4.6% |
| Public, Non-profit and Education | 22,968 | 23,970 | -4.2% | 22,260 | 3.2% |
| Retail and CPG | 33,784 | 33,494 | 0.9% | 33,031 | 2.3% |
| Telecom, Media and Entertainment | 10,739 | 13,244 | -18.9% | 11,054 | -2.8% |
{2}------------------------------------------------
3
Nagarro Group
Key figures – Nine months
| Nine-month period ended September 30 | 2025 | 2024 | Change |
|---|---|---|---|
| kEUR | kEUR | % | |
| Revenue | 753,430 | 725,357 | 3.9% |
| Cost of revenues | 510,043 | 502,082 | 1.6% |
| Gross profit | 243,488 | 223,461 | 9.0% |
| Adjusted EBITDA | 104,796 | 109,278 | -4.1% |
| Revenue by geography | |||
| North America | 260,155 | 260,694 | -0.2% |
| Central Europe | 225,672 | 206,293 | 9.4% |
| Rest of Europe | 95,380 | 88,927 | 7.3% |
| Rest of World | 172,222 | 169,443 | 1.6% |
| Revenue by country | |||
| Germany | 177,164 | 158,115 | 12.0% |
| US | 258,522 | 256,880 | 0.6% |
| Revenue by industry | |||
| Automotive, Manufacturing and Industrial | 186,580 | 160,014 | 16.6% |
| Energy, Utilities and Building Automation | 52,734 | 56,897 | -7.3% |
| Financial Services and Insurance | 93,611 | 94,587 | -1.0% |
| Horizontal Tech | 39,675 | 46,902 | -15.4% |
| Life Sciences and Healthcare | 53,331 | 52,712 | 1.2% |
| Management Consulting and Business Information | 56,839 | 44,015 | 29.1% |
| Public, Non-profit and Education | 67,516 | 65,797 | 2.6% |
| Retail and CPG | 100,051 | 99,780 | 0.3% |
| Telecom, Media and Entertainment | 33,739 | 41,418 | -18.5% |
| Travel and Logistics | 69,354 | 63,237 | 9.7% |
{3}------------------------------------------------
| Nine-month period ended September 30 | 2025 | 2024 |
|---|---|---|
| % | % | |
| Revenue concentration (by customer) | ||
| Top 5 | 15.1% | 14.4% |
| Top 6-10 | 8.8% | 9.3% |
| Outside of Top 10 | 76.1% | 76.3% |
Gross profit, gross margin and Adjusted EBITDA are neither required by, nor presented in accordance with IFRS. Non-IFRS measures should not be considered in isolation or as a substitute for results under IFRS.
Gross profit is calculated on the basis of total performance which is the sum of revenue and own work capitalized.
Rounding differences may arise when individual amounts or percentages are added together.
{4}------------------------------------------------
Index
Section A
| Interim | aroun | manac | iement | report |
|---|---|---|---|---|
| 1111611111 | gi oup | IIIaiiay | ieiiieiir | IEDUI |
| 1. | ||
|---|---|---|
| 2. | The business environment and Nagarro's response | 7 |
| 3. | Financial performance: review and analysis | 8 |
| 4. | Financial position | 12 |
| 5. | Outlook | 15 |
| 6. | Developments after September 30, 2025 | 15 |
| Sec | ction B | |
| Inte | erim condensed information | |
| Int | terim condensed consolidated statement of financial position | 17 |
| Int | terim condensed consolidated statement of comprehensive income | 19 |
| Int | terim condensed consolidated statement of changes in equity | 21 |
| terim condensed consolidated statement of cash flows | ||
| Ot | ther notes | 24 |
| Sec | ction C | |
| lmp | portant information | |
| Fir | nancial calendar | 28 |
| lm | nprint | 28 |
{5}------------------------------------------------


{6}------------------------------------------------
7
1.Overview
Nagarro continued its recovery through an enhanced focus on execution. In Q3 2025, revenue grew 9.4% YoY in constant currency, and 4.8% in Euro terms. Organic YoY revenue growth for the quarter was 8.2% in constant currency and 3.7% in Euro terms. Compared to Q2 2025, revenue grew 2.8% QoQ in constant currency, which was 1.0% QoQ in Euro terms. Nagarro's 9M 2025 YoY revenue growth over 9M 2024 was 6.3% in constant currency, and 3.9% in Euro terms.
Gross profit as a percentage of revenue was 33.1% in Q3 2025, compared with 30.6% in Q1 2025, 33.2% in Q2 2025. The resulting 9M 2025 number was 32.3%.
Adjusted EBITDA as a percentage of revenue was 17.3% in Q3 2025, compared with 12.2% in Q1 2025 and 12.1% in Q2 2025. The Q1 2025 and Q2 2025 numbers had been depressed by the non-cash effects of re-evaluation of intra-group loans not denominated in Euro. The Adjusted EBITDA margin for 9M 2025 was 13.9%.
The number of clients generating over 1 million Euro in revenue in the trailing twelve months was 187 on September 30, 2025 compared to 186 a year ago. The company had a net increase of 233 professionals in Q3 2025, following a reduction of 199 and 49 professionals in Q1 2025 and Q2 2025 respectively. On September 30, 2025, Nagarro had 17,680 professionals, out of which 16,135 were professionals in engineering.
2.The business environment and Nagarro's response
The demand environment remained relatively soft in 9M 2025. In October 2025, Gartner revised its forecast for 2025 global IT services spending growth, denominated in dollars, to 6.5%, down from its 9% estimate in January 2025. Further, the spend on digital engineering, a subset of IT services in which Nagarro specializes, tends to be rather discretionary, and it remained subdued due to economic, policy and technological uncertainties.
Given the slow demand environment, Nagarro focused on controlling overall costs, even while preparing for future growth driven by AI transformation opportunities. Company morale remained high, and attrition and wage inflation remained moderate. The job environment for top talent remained competitive in some countries, in India in particular. Client loyalty and client satisfaction, a critical aspect of our business, remained strong.
{7}------------------------------------------------
3.Financial performance: review and analysis
Buffeted by economic, policy and technological uncertainties, our clients were relatively cautious about commissioning new projects and ramping up existing initiatives. This resulted in moderate revenue growth for Nagarro in the period.
Nagarro's enhanced execution drove a healthy gross margin in the 9M 2025 period. However, Adjusted EBITDA was impacted negatively by the weakness of the US dollar against the Euro, with a large, non-cash impact in Q1 2025 and Q2 2025 due to the remeasurement of intra-group loans within Nagarro group (Nagarro does not adjust for such re-evaluation in Adjusted EBITDA calculations). Q3 Adjusted EBITDA margin was excellent since there was little impact of such re-evaluation.
A. Results for 9M 2025
Revenue
Nagarro's revenues grew to €753.4 million in 9M 2025 from €725.4 million in 9M 2024, a growth of 3.9%. In constant currency, 9M YoY revenue growth was 6.3%.
Gross margin and Adjusted EBITDA
Gross margin and Adjusted EBITDA are non-IFRS alternative performance measures, selected to provide supplemental information for a meaningful comparison of the company's financial performance with industry peers and across reporting periods.
Gross margin is the ratio of gross profit to revenue, where gross profit is calculated on the basis of total performance which is sum of revenue and own work capitalized. Cost of revenues is the total direct cost needed to service the revenue. It includes direct costs related to colleagues (employees and freelancers) allocated to the performance of customer services, costs related to travel of these colleagues, cost of licenses and other, smaller, reimbursable and non-reimbursable cost components. It excludes the costs of management of the Global Business Units (GBUs) and the cost of consultative sales and thought leadership across Centres of Excellence (CoEs) and GBUs.
The table below shows the gross margin for the nine-months period ended September 30, 2025:
| Nine-month period ended September 30 | 2025 | 2024 |
|---|---|---|
| mEUR | mEUR | |
| Revenue | 753.4 | 725.4 |
| Own work capitalized | 0.1 | 0.2 |
| Total performance | 753.5 | 725.5 |
| Cost of revenues | (510.0) | (502.1) |
| Gross profit | 243.5 | 223.5 |
| Gross margin (as % of revenue) | 32.3% | 30.8% |
We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization (EBITDA) adjusted to exclude effects that we consider extraordinary, such as impairment of goodwill, purchase price adjustments, badwill, foreign exchange effects on purchase price, sale of equity investments, share based payment arrangements cost, acquisition expenses, retention bonus and non-capitalized earn-out expenses related to acquisitions, expenses relating to the strategic review of company's listing and privatization choices and subsequent exploration of the take-private option and, in recent periods, additional audit fee and other expenses. Adjusted EBITDA is calculated according to economic criteria and is independent from IFRS rules. Therefore, the Adjusted EBITDA is more suitable for comparing operating performance over several periods. A more detailed definition can be found in the 2024 consolidated financial statements.
{8}------------------------------------------------
The reconciliation between Adjusted EBITDA and EBITDA is as follows:
| Nine-month period ended September 302025 | 2024 |
|---|---|
| mEUR | mEUR |
| EBITDA108.5 | 100.7 |
| Adjustment for special items | |
| Income from purchase price adjustments- | (0.1) |
| Exchange loss (gain) on purchase price components(0.0) | (0.0) |
| Stock option and employee share participation program expense(9.3) | 2.3 |
| Acquisition expense0.2 | - |
| Retention bonus expense as part of share purchase agreement of the acquired entities2.0 | 2.3 |
| Non-capitalized earn-out expense relating to acquisitions0.5 | 3.2 |
| Other expenses1.6 | - |
| Expenses relating to strategic review of listing and privatization choices- | 0.4 |
| Expenses relating to the exploration of the take-private option- | 0.6 |
| Additional audit fee1.3 | - |
| Total adjustment for special items(3.7) | 8.6 |
| Adjusted EBITDA104.8 | 109.3 |
| Revenues753.4 | 725.4 |
| Adjusted EBITDA (as % of revenues)13.9% | 15.1% |
CSAT and NPS scores
Our key non-financial KPIs are our client satisfaction (CSAT) score and Net Promoter Score (NPS). Both the CSAT and the NPS are measured via a standardized client satisfaction survey. This survey is sent every quarter to the person responsible for project success on the client side – excluding very small engagements, defined since Q1 2025 as projects with no more than 3 FTEs of average monthly staffing in the quarter. Before Q1 2025, the projects excluded from the survey were defined as those with staffing in only one month, or in two months with no more than 1 FTE in each. The threshold for sending out the survey was changed based on client feedback and the low response levels for these small projects.
This survey also does not cover engagements via acquisitions in up to 5 quarterly cycles after the completion of their integration into Nagarro's systems and processes. Despite these caveats, the CSAT and NPS results are very central to our management system. Each CSAT question asks the client's frequency of satisfaction with a particular aspect of our services. The responses collected are monitored carefully at the aggregate level, at the question level, and at the project level. While minor fluctuations are to be expected, any significant trends are discussed and addressed. Our CSAT score was 94.3%, 93.2% and 93.1% for Q1 2025, Q2 2025 and Q3 2025 respectively resulting in a 9M 2025 score of 93.5% with the new exclusion policy for very small engagements (with the old policy 9M 2024: 91.6%, Q1 2024: 91.8%, Q2 2024: 91.9%, Q3 2024: 91.0% and Q4 2024: 92.4%). We expect this KPI to remain in the region of 93.0% in 2025.
The NPS question posed in the survey is: "On a scale of 1-10, how likely are you to recommend Nagarro to a friend or colleague?" Promoters are those who give a score of 9 or 10, Passives are those who give a score of 7 or 8, and Detractors are those who respond with a score below 7. The NPS score is calculated as (number of Promoters – number of Detractors) * 100/ (total number of NPS responses) and rounded to the nearest whole number. Nagarro's NPS score for Q1 2025 was 69, Q2 2025 was 66 and Q3 2025 was 69 resulting in a 9M 2025 score of 68 with the new exclusion policy for very small engagements (with the old policy, 9M 2024: 62, Q1 2024: 66, Q2 2024: 62, Q3 2024: 59 and Q4 2024: 62).
{9}------------------------------------------------
B. Result of operations
Revenue
Nagarro's revenues grew to €254.6 million in Q3 2025 from €242.9 million in Q3 2024, a growth of 4.8%. In constant currency, Q3 2025 YoY revenue growth was 9.4%.
Nagarro's revenues grew to €753.4 million in 9M 2025 from €725.4 million in 9M 2024, a growth of 3.9%. In constant currency, 9M YoY revenue growth was 6.3%.
Nagarro operates across a variety of industries. The focus on consumer experience underlies the digital transformation of almost every industry, while the technology used for this also cuts across industries. Innovation occurs increasingly often at the overlaps of the traditional industry definitions. Yet, each industry also requires specialized knowledge, and we have been investing in developing such specialized knowledge within each industry.
Industries with robust growth in 9M 2025 over 9M 2024 included "Management Consulting and Business Information" (29.1%), "Automotive, Manufacturing and Industrial" (16.6%) and "Travel and logistics" (9.7%).
Industries with negative growth in 9M 2025 over 9M 2024 included "Telecom, Media and Entertainment" (-18.5%), "Horizontal Tech" (-15.4%) and "Energy, Utilities and Building Automation" (-7.3%).
In the geographical revenue distribution, in 9M 2025 Nagarro generated 34.5% of its revenue from North America (9M 2024: 35.9%), 30.0% of its revenue from Central Europe (9M 2024: 28.4%), 22.9% of its revenue from Rest of World (9M 2024: 23.4%) and 12.7% of its revenue from Rest of Europe (9M 2024:12.3%).
The revenue from our top 5 clients as a percentage of total revenue grew to 15.1% in 9M 2025 from 14.4% in 9M 2024. The revenue from the next 5 largest clients declined to 8.8% in 9M 2025 from 9.3% in 9M 2024, while the revenue from clients outside the top 10 was almost steady at 76.1% in 9M 2025 compared to 76.3% 9M 2024.
The top 5 currencies that contributed significantly to our revenues are listed below (in € million):
| Nine-month period ended September 30Revenue currency | 2025mEUR | 2024mEUR |
|---|---|---|
| EUR | 293.8 | 266.0 |
| USD | 274.3 | 290.7 |
| INR | 68.0 | 68.5 |
| AED | 25.4 | 21.1 |
| GBP | 18.9 | 14.1 |
Gross profit and Adjusted EBITDA
Gross profit grew by €7.7 million to €84.2 million in Q3 2025 from €76.5 million in Q3 2024. Gross margin increased to 33.1% in Q3 2025 as compared to 31.5% in Q3 2024. Adjusted EBITDA increased by €9.4 million from €34.6 million (14.3% of revenue) in Q3 2024 to €44.0 million (17.3% of revenue) in Q3 2025.
Our net adjustments to EBITDA in Q3 2025 amount to €0.6 million (Q3 2024: €2.8 million) and the most significant adjustments are other expenses amounting to €1.0 million (Q3 2024: Nil), retention bonus of €0.6 million (Q3 2024: €0.7 million), expense on earnouts of €0.5 million (Q3 2024: €0.9 million) from past acquisitions which has been offset by expense reversal on account of employee stock options and ESPP amounting to €1.8 million (Q3 2024: expense of €0.6 million).
Gross profit grew by €20.0 million to €243.5 million 9M 2025 from €223.5 million in 9M 2024. Gross margin increased to 32.3% in 9M 2025 as compared to 30.8% in 9M 2024. Adjusted EBITDA decreased by €4.5 million from €109.3 million (15.1% of revenue) in 9M 2024 to €104.8 million (13.9% of revenue) in 9M 2025 mainly because of negative foreign currency impact. During the period, foreign currency losses increased by €19.1 million to €19.7 million (9M 2024: €0.6 million) mainly due to the unrealized foreign exchange loss on account of remeasurement of intra-group loans within Nagarro group amounting to €15.8 million and net
{10}------------------------------------------------

loss from foreign exchange forward transactions amounting to €3.7 million incurred during the period. The same has been offset by increase in gross profit amounting to €20.0 million. Balance decrease pertains to increase in personnel costs and other operating expenses in the normal course of business.
Our most significant adjustments to EBITDA in 9M 2025 are expense reversal on account of employee stock options and ESPP amounting to €9.3 million (9M 2024: an expense of €2.3 million) which has been offset by retention bonus expense amounting to €2.0 million (9M 2024: €2.3 million), other expenses amounting to €1.6 million (9M 2024: Nil), earnout expense amounting to €0.5 million (9M 2024: €3.2 million) and an additional audit fee of €1.3 million (9M 2024: Nil).
Please note that gross margin, gross profit and Adjusted EBITDA are non-IFRS KPIs, as defined in the Annual Report 2024.

EBITDA, EBIT and net profit
EBITDA increased by €11.6 million from €31.9 million in Q3 2024 to €43.5 million in Q3 2025. EBIT increased by €12.4 million from €22.5 million in Q3 2024 to €34.9 million in Q3 2025. Net profit increased by €8.7 million from €12.7 million in Q3 2024 to €21.4 million in Q3 2025. Further, compared to Q3 2024, in Q3 2025 there was a decrease in interest expense of €0.2 million, decrease in interest income of €0.3 million and decrease in depreciation and amortization expense of €0.7 million.
EBITDA increased by €7.9 million from €100.7 million in 9M 2024 to €108.5 million in 9M 2025. EBIT increased by €10.1 million from €72.2 million in 9M 2024 to €82.3 million in 9M 2025. Net profit decreased by €0.4 million from €41.3 million in 9M 2024 to €41.0 million in 9M 2025. Further, compared to 9M 2024, in 9M 2025 there was a slight decrease in depreciation and amortization expense of €2.3 million, interest expense of €0.2 million and decrease in interest income of €0.4 million.
The top 5 currencies that contributed significantly to our expenses (net of operating income) including taxes but excluding foreign currency income and expenses, and expenses relating to inflationary accounting are listed below (in € million):
| Nine-month period ended September 30Expenses currency | 2025mEUR | 2024mEUR |
|---|---|---|
| INR | 281.4 | 280.6 |
| EUR | 187.1 | 180.0 |
| USD | 89.4 | 88.9 |
| RON | 40.4 | 43.5 |
| TRY | 18.1 | 20.2 |
{11}------------------------------------------------
4.Financial position
Capital structure
Since September 23, 2022, Nagarro SE has had a Euro-denominated revolving syndicated credit facility agreement with five European credit institutions amounting to €350 million with an option to further increase the loan facility amount to €450 million. The utilized balance of this facility amounts to €288.5 million as of September 30, 2025.
We target a balanced debt-to-equity ratio and equity-to-total assets ratio that preserves flexibility for the company, allowing it to react to business opportunities and to changes in macroeconomic conditions.
On February 5, 2025, the Management Board of Nagarro SE resolved to make use of the authorization, which was granted by the shareholders' meeting of October 30, 2020, pursuant to Sec. 71 para. 1 no. 8 of the German Stock Corporation Act (Aktiengesetz, AktG) to repurchase shares of the Company until September 23, 2025, provided that these shares, together with other treasury shares which the Company has already acquired and still holds or which are attributable to it pursuant to Sections 71a et seq. of the German Stock Corporation Act (AktG), do not at any time account for more than 10% of the share capital. Accordingly, Nagarro SE has purchased 684,384 treasury shares amounting to €50.1 million during the nine-month period ended September 30, 2025.
Net debt is total liabilities to banks plus lease liabilities less cash. Net debt to adjusted EBITDA is net debt divided by adjusted EBITDA of the trailing twelve months. The net debt increased by €51.1 million to €242.6 million (net debt to adjusted EBITDA ratio of 1.7x) as of September 30, 2025, as against €191.5 million (net debt to adjusted EBITDA ratio of 1.3x) as of December 31, 2024.
Liquidity
Net cash inflow/ (outflow) for the period:

The company's liquidity position at the end of 9M 2025 was comfortable. The current assets were €414.3 million, of which cash was €129.4 million. The current liabilities were €190.8 million, yielding a working capital of €223.5 million.
Our total cash outflow was €49.2 million in 9M 2025 against cash inflow of €33.1 million in 9M 2024. Cash flows for 9M 2025 are presented in the same format as the full year financials for financial year 2024.
Our operating cash flow increased by €12.2 million from €64.9 million in 9M 2024 to €77.1 million in 9M 2025. Main impact for this increase comes from other non-cash income and expenses amounting to €7.2 million (majorly due to unrealized foreign exchange loss on intra-group loans within Nagarro group amounting to €15.8 million, expenses for foreign exchange forward transactions amounting to €3.3 million, offset by decrease in stock option and employee share participation program expense amounting to €11.5 million). Further, better collections in 9M 2025 increased operating cash flows from changes in net working
{12}------------------------------------------------

capital by €5.3 million. The increase in operating cash flows has been offset by increase in payment of income taxes amounting to €10.1 million mainly due to withholding taxes paid on intra-group transfer of dividend within Nagarro group.
Further, we reduced the utilization of funds under the non-recourse factoring program by €3.9 million during 9M 2025. Operating cash flow adjusted for changes in factoring (including interest on factored amounts) was €81.0 million in 9M 2025 as compared to €70.6 million in 9M 2024.
Days of sales outstanding, calculated based on quarterly revenue and including both contract assets and trade receivables, has decreased from 88 days on December 31, 2024 to 85 days on September 30, 2025.
The cash outflow from investing activities in 9M 2025 was €8.9 million, mainly due to purchase of property, plant and equipment amounting to €6.1 million and payment of acquisition obligations of €4.4 million. This has been offset by interest received during the period amounting to €2.0 million. The cash outflow from investing activities in 9M 2024 was €6.2 million.
The cash outflow from financing activities in 9M 2025 was €117.4 million as compared to €25.5 million in 9M 2024. Cash outflow in 9M 2025 was primarily on account of purchase of treasury shares amounting to €50.1 million, net repayment of bank loans of €24.3 million, lease payments of €16.6 million, interest payment of €13.8 million and dividend paid during the period amounting to €12.6 million.
Also refer "Notes to the interim condensed consolidated statement of cash flows" in other notes of Section B.
Countries with the top 5 bank balances are listed below:
| Countries | September 30, 2025 | December 31, 2024 |
|---|---|---|
| mEUR | mEUR | |
| Germany | 56.1 | 93.8 |
| India | 15.7 | 36.8 |
| United States of America | 11.8 | 11.4 |
| Romania | 5.3 | 5.8 |
| Singapore | 5.1 | 0.8 |
{13}------------------------------------------------
Net assets

Total assets declined by €45.4 million to €750.3 million as of September 30, 2025, as against €795.7 million as of December 31, 2024. Of these, non-current assets decreased by €4.7 million to €336.0 million as of September 30, 2025, as against €340.7 million as of December 31, 2024. Within non-current assets, goodwill decreased by €18.0 million on account of currency differences mainly because of weakening of the US dollar against the Euro, offset by increase in right of use assets from leases by €15.8 million to €69.1 million (mainly due to net addition of new leases of €32.8 million offset by amortization of right of use assets of €17.0 million). Addition to right of use assets primarily represents new office space taken on lease in India. Further, intangible assets decreased by €5.0 million to €38.4 million (mainly due to currency differences on account of translation of assets because of strengthening of Euro against the currencies in which these assets are held and amortization). Current assets declined by €40.7 million to €414.3 million as of September 30, 2025, as against €455.0 million as of December 31, 2024 mainly on account of decrease in cash and cash equivalents by €63.2 million to €129.4 million as of September 30, 2025, as against €192.6 million as of December 31, 2024. The same has been offset by increase in income tax receivables by €21.0 million to €27.4 million due to advance tax payments in the nine-month period. Further, contract assets, trade receivables, other current financial assets and other current assets together increased marginally by €1.5 million.
Total liabilities grew by €4.5 million to €577.5 million as of September 30, 2025, as against €573.0 million as of December 31, 2024. Non-current liabilities decreased by €17.1 million to €386.8 million as of September 30, 2025, as against €403.9 million as of December 31, 2024 mainly on account of repayment of part of the bank loan amounting to €30.3 million. The decrease in loans and borrowings has been offset by increase in non-current lease liabilities by €16.3 million to €52.3 million as of September 30, 2025 from €36.1 million as of December 31, 2024. Current liabilities increased by €21.6 million to €190.8 million as of September 30, 2025, as against €169.1 million as of December 31, 2024 primarily due to increase in income tax liabilities by €25.7 million, other financial liabilities by €7.3 million and trade payables by €4.2 million. This has been offset by decrease in short term employee benefits liabilities by €9.4 million (mainly on account of reduction in fair values of cash-settled SOPs) and other current liabilities by €4.4 million.
Net assets represented by total equity declined by €49.9 million to €172.8 million as of September 30, 2025, as against €222.7 million as of December 31, 2024. Equity decreased mainly due to purchase of treasury shares amounting to €50.1 million, dividend payment amounting to €12.6 million and negative other comprehensive income (OCI) amounting to €28.7 million (mainly due to negative impact of foreign currency related to translation of group entities' balance sheet items from their functional currency to group's presentation currency on the reporting date) which has been offset by positive current period's profits amounting to €41.0 million.
{14}------------------------------------------------
5.Outlook
We maintain the expectations expressed in the half-yearly financial report.
6.Developments after September 30, 2025
In the period between the balance sheet date of September 30, 2025, and the approval of the report by the Management Board on November 13, 2025, for publication, Nagarro's business has not changed significantly.
{15}------------------------------------------------
condensed information for the nine-month period ended September 30, 2023 in accordance with IFRS
Interim
{16}------------------------------------------------

Interim condensed consolidated statement of financial position
| September 30, | December 31, | |
|---|---|---|
| Assets | 2025 | 2024 |
| in kEUR | ||
| Intangible assets | 38,425 | 43,396 |
| Goodwill | 196,237 | 214,242 |
| Property, plant and equipment | 8,453 | 10,029 |
| Right of use assets | 69,098 | 53,274 |
| Non-current contract assets | 396 | 432 |
| Other non-current financial assets | 4,013 | 2,133 |
| Other non-current assets | 592 | 663 |
| Deferred tax assets | 18,794 | 16,491 |
| Non-current assets | 336,007 | 340,660 |
| Contract assets | 29,016 | 15,529 |
| Trade receivables | 205,571 | 219,332 |
| Other current financial assets | 7,905 | 7,850 |
| Other current assets | 15,011 | 13,324 |
| Income tax receivables | 27,441 | 6,440 |
| Cash and cash equivalents | 129,354 | 192,567 |
| Current assets | 414,298 | 455,041 |
| Total assets | 750,305 | 795,701 |
{17}------------------------------------------------
| September 30, | December 31, | |
|---|---|---|
| Equity and Liabilities | 2025 | 2024 |
| in kEUR | ||
| Share capital | 13,776 | 13,776 |
| Treasury shares, at cost | (89,838) | (39,757) |
| Capital reserve | 241,574 | 241,030 |
| Profit carried forward | 252,149 | 215,631 |
| Net profit for the period | 40,972 | 49,156 |
| Changes in equity recognized directly in equity | (260,612) | (260,612) |
| Other comprehensive income | (25,261) | 3,437 |
| Total equity | 172,759 | 222,660 |
| Non-current loans and borrowings | 290,507 | 320,835 |
| Non-current lease liabilities | 52,348 | 36,086 |
| Long-term employee benefits liabilities | 21,350 | 22,581 |
| Other long-term provisions | 487 | 434 |
| Other non-current financial liabilities | 6,872 | 5,743 |
| Non-current liabilities from acquisitions | 4,255 | 4,468 |
| Deferred tax liabilities | 10,975 | 13,785 |
| Non-current liabilities | 386,793 | 403,932 |
| Current loans and borrowings | 10,661 | 8,777 |
| Current lease liabilities | 18,417 | 18,396 |
| Short-term employee benefits liabilities | 6,732 | 16,085 |
| Other short-term provisions | 27,704 | 26,365 |
| Current contract liabilities | 10,420 | 14,105 |
| Trade payables | 21,240 | 17,076 |
| Current liabilities from acquisitions | 100 | 1,405 |
| Other current financial liabilities | 47,823 | 40,478 |
| Other current liabilities | 12,602 | 17,022 |
| Income tax liabilities | 35,054 | 9,399 |
| Current liabilities | 190,753 | 169,108 |
| Total liabilities | 577,546 | 573,041 |
| Equity and liabilities | 750,305 | 795,701 |
{18}------------------------------------------------

Interim condensed consolidated statement of comprehensive income
| Q3 | Q3 | 9M | 9M | |
|---|---|---|---|---|
| Profit or Loss | 2025 | 2024 | 2025 | 2024 |
| in kEUR | ||||
| Revenue | 254,569 | 242,925 | 753,430 | 725,357 |
| Own work capitalized | 7 | 72 | 101 | 186 |
| Other operating income | 7,732 | 3,366 | 19,551 | 12,997 |
| Cost of materials | (21,631) | (16,502) | (61,609) | (51,065) |
| Staff costs | (171,674) | (172,460) | (512,486) | (519,087) |
| Impairment of trade receivables, contract assets and other financial assets | 352 | (329) | 716 | (719) |
| Other operating expenses | (25,888) | (25,204) | (91,195) | (67,017) |
| Earnings before interest, taxes, depreciation and amortization (EBITDA) | 43,468 | 31,870 | 108,507 | 100,652 |
| Depreciation, amortization and impairment | (8,601) | (9,334) | (26,175) | (28,432) |
| Earnings before interest and taxes (EBIT) | 34,867 | 22,536 | 82,332 | 72,220 |
| Finance income | 596 | 857 | 2,013 | 2,395 |
| Finance costs | (4,805) | (5,037) | (15,329) | (15,549) |
| Earnings before taxes (EBT) | 30,657 | 18,355 | 69,016 | 59,066 |
| Income taxes | (9,257) | (5,607) | (28,044) | (17,743) |
| Profit for the period | 21,400 | 12,748 | 40,972 | 41,323 |
| Q3 | Q3 | 9M | 9M | |
| Other comprehensive income | 2025 | 2024 | 2025 | 2024 |
| in kEUR | ||||
| Items that will not be reclassified to profit or loss | ||||
| Actuarial gains (losses) | 279 | 2,187 | (114) | 1,799 |
| Tax effects | (69) | (551) | 64 | (437) |
| 210 | 1,636 | (50) | 1,362 | |
| Items that may be reclassified to profit or loss | ||||
| Foreign exchange differences (including effect of Türkiye hyperinflation) | (3,160) | (11,725) | (29,018) | (3,208) |
| Tax effects | 51 | (47) | 371 | (487) |
| (3,109) | (11,773) | (28,648) | (3,695) | |
| Other comprehensive income for the period | (2,899) | (10,136) | (28,698) | (2,333) |
| Total comprehensive income for the period | 18,501 | 2,612 | 12,274 | 38,989 |
{19}------------------------------------------------

| Q3 | Q3 | 9M | 9M | |
|---|---|---|---|---|
| Basic earnings per share ('Basic EPS'): | 2025 | 2024 | 2025 | 2024 |
| Number of shares | ||||
| - based on weighted average | 12,637,734 | 13,322,118 | 12,879,364 | 13,322,118 |
| - based on outstanding shares | 12,637,734 | 13,322,118 | 12,637,734 | 13,322,118 |
| Basic EPS in EUR | ||||
| - based on weighted average | 1.69 | 0.96 | 3.18 | 3.10 |
| - based on outstanding shares | 1.69 | 0.96 | 3.24 | 3.10 |
| Diluted earnings per share ('Diluted EPS'): | ||||
| Number of shares | ||||
| - based on weighted average | 12,641,365 | 13,323,599 | 12,883,814 | 13,323,800 |
| - based on outstanding shares | 12,641,365 | 13,323,599 | 12,642,184 | 13,323,800 |
| Diluted EPS in EUR | ||||
| - based on weighted average | 1.69 | 0.96 | 3.18 | 3.10 |
{20}------------------------------------------------

Interim condensed consolidated statement of changes in equity
| Share capital | Othercomprehensiveincome | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Treasury shares | Capital reserve | Profit carried forward | Net profit for the period | Changes in equity recognized directlyin equity | Foreign currency reserve | Actuarial gain or loss on pensionprovisions | Total equity | ||
| in kEUR | |||||||||
| Balance as at January 1, 2025 | 13,776 | (39,757) | 241,030 | 215,631 | 49,156 | (260,612) | 6,539 | (3,102) | 222,661 |
| Profit for the period | – | – | – | – | 40,972 | – | – | – | 40,972 |
| Other comprehensive income for the period | – | – | – | – | – | – | (28,648) | (50) | (28,698) |
| Total comprehensive income for theperiod | – | – | – | – | 40,972 | – (28,648) | (50) | 12,274 | |
| Transfer of profit or loss for the previous yearto profit carried forward | – | – | – | 49,156 | (49,156) | – | – | – | – |
| Purchase of treasury shares | – | (50,082) | – | – | – | – | – | – | (50,082) |
| Dividend declared | – | – | – | (12,638) | – | – | – | – | (12,638) |
| Share capital issued | – | – | – | – | – | – | – | – | – |
| Transfer of capital reserve | – | – | – | – | – | – | – | – | – |
| Stock option and employee shareparticipation program expense | – | – | 544 | – | – | – | – | – | 544 |
| Balance as at September 30, 2025 | 13,776 | (89,838) | 241,574 | 252,149 | 40,972 | (260,612) (22,109) | (3,153) | 172,759 |
{21}------------------------------------------------
| Share capital | Othercomprehensiveincome | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Treasury shares | Capital reserve | Profit carried forward | Net profit for the period | Changes in equity recognized directlyin equity | Foreign currency reserve | Actuarial gain or loss on pensionprovisions | Total equity | ||
| in kEUR | |||||||||
| Balance as at January 1, 2024 | 13,776 | (39,757) | 251,717 | 166,476 | 49,155 | (260,612) | (6,964) | (3,325) | 170,466 |
| Profit for the period | – | – | – | – | 41,323 | – | – | – | 41,323 |
| Other comprehensive income for the period | – | – | – | – | – | – | (3,695) | 1,362 | (2,333) |
| Total comprehensive income for theperiod | – | – | – | – | 41,323 | – | (3,695) | 1,362 | 38,989 |
| Transfer of profit or loss for the previous yearto profit carried forward | – | – | – | 49,155 | (49,155) | – | – | – | – |
| Purchase of treasury shares | – | – | – | – | – | – | – | – | – |
| Dividends | – | – | – | – | – | – | – | – | – |
| Share capital issued | – | – | – | – | – | – | – | – | – |
| Transfer of capital reserve | – | – | – | – | – | – | – | – | – |
| Stock option and employee shareparticipation program expense | – | – | 2,248 | – | – | – | – | – | 2,248 |
| Balance as at September 30, 2024 | 13,776 | (39,757) | 253,965 | 215,631 | 41,323 | (260,612) (10,659) | (1,963) | 211,704 |
{22}------------------------------------------------
Interim condensed consolidated statement of cash flows
| Nine-month period ended September 30 | 2025 | 2024 | |
|---|---|---|---|
| in kEUR | |||
| Cash flows from operating activities | |||
| EBIT | 82,332 | 72,220 | |
| Depreciation, amortization and impairments of non-current assets | 26,175 | 28,432 | |
| Change in long-term employee benefits liabilities | 2,314 | 2,111 | |
| Other non-cash income and expenses | 13,646 | 6,474 | |
| Income taxes paid | (28,679) | (18,557) | |
| Cash flows from changes in net working capital | (14,790) | (20,118) | |
| Net cash inflow (outflow) from non-recourse factoring | (3,895) | (5,665) | |
| Net cash inflow from operating activities | 77,104 | 64,898 | |
| Cash flows from investing activities | |||
| Payments for property, plant and equipment and intangible assets | (6,055) | (3,837) | |
| Proceeds from sale of property, plant and equipment | - | 152 | |
| Redemption of / (Investment in) fixed deposits | (466) | 4,455 | |
| Interest received | 2,032 | 2,703 | |
| Acquisition of subsidiaries, net of cash acquired | (4,370) | (9,705) | |
| Net cash outflow from investing activities | (8,860) | (6,232) | |
| Cash flows from financing activities | |||
| Purchase of treasury shares | (50,082) | - | |
| Dividend paid | (12,623) | - | |
| Proceeds from bank loans | 7,673 | 10,979 | |
| Repayment of bank loans | (31,981) | (3,979) | |
| Principal elements of lease payments | (16,584) | (18,922) | |
| Interest paid | (13,836) | (13,616) | |
| Net cash outflow from financing activities | (117,433) | (25,538) | |
| Total cash flow | (49,188) | 33,128 | |
| Effects of exchange rate changes on cash and cash equivalents | (9,560) | (731) | |
| Total changes in cash and cash equivalents | (58,749) | 32,397 | |
| Cash and cash equivalents at the beginning of period | 186,879 | 107,777 | |
{23}------------------------------------------------
Other notes
Accounting policies
The accounting policies have not changed compared to the accounting policies disclosed in the consolidated financial statements for the year 2024. The quarterly statement of Nagarro SE for Q3 and the nine-month period ended September 30, 2025, has not been reviewed by an auditor or has not been audited according to section 115(5) WpHG (German Securities Trading Act).
Treasury shares
Nagarro SE acquired 684,384 treasury shares during the nine-month period ended September 30, 2025 and held 1,138,251 units of treasury shares as at September 30, 2025 and 453,867 units as at December 31, 2024. Reconciliation is as follows:
| Sep 30, 2025 | Sep 30, 2025 | Dec 31, 2024 | Dec 31, 2024 | |
|---|---|---|---|---|
| Numbers | kEUR | Numbers | kEUR | |
| Opening balance | 453,867 | 39,757 | 453,867 | 39,757 |
| Acquired during the year | 684,384 | 50,082 | - | - |
| Sale during the year | - | - | - | - |
| Closing balance | 1,138,251 | 89,838 | 453,867 | 39,757 |
Notes to the interim condensed consolidated statement of cash flows
(i) Reconciliation of net cash flows from non-recourse factoring
Net cash flows from non-recourse factoring reconcile to the cashflows from operating activities as follows:
| Cash flows | Currencydifferences | Interest | |||
|---|---|---|---|---|---|
| Jan 1,2025 | 2025 | 2025 | 2025 | Sep 30,2025 | |
| kEUR | kEUR | kEUR | kEUR | kEUR | |
| Net cash flows: | |||||
| Trade receivables derecognized | 25,274 | (7,891) | (2,373) | 839 | 15,848 |
| Liabilities from factoring | (5,688) | 3,997 | 468 | - | (1,223) |
| 19,586 | (3,895) | (1,906) | 839 | 14,625 | |
{24}------------------------------------------------

| Cash flows | Currencydifferences | Interest | |||
|---|---|---|---|---|---|
| Jan 1,2024 | 2024 | 2024 | 2024 | Sep 30,2024 | |
| kEUR | kEUR | kEUR | kEUR | kEUR | |
| Net cash flows: | |||||
| Trade receivables derecognized | 26,188 | (7,204) | (292) | 1,126 | 19,818 |
| Liabilities from factoring | (2,346) | 1,539 | (34) | - | (840) |
| 23,842 | (5,665) | (326) | 1,126 | 18,978 |
The changes in trade receivables derecognized and liabilities from factoring are disclosed as net cash flows from nonrecourse factoring while change in gross trade receivables is shown as "Trade receivables, contract assets and contract liabilities" under changes in net working capital.
(ii) Others
In the interim condensed consolidated statement of cash flows for 9M 2025, Nagarro has included the unrealized gain/ loss on intra-group loans within Nagarro group under "Other non-cash income and expenses" in "Net cashflow from operating activities" leading to a positive impact of kEUR 15,842 with a corresponding decrease in "Effects of exchange rate changes on cash and cash equivalents". Other impacts of unrealized gain/loss on the balance sheet items relating to working capital have an equal impact on "Other non-cash income and expenses" and "Cash flows from changes in net working capital" with a zero impact on "Net cash inflow from operating activities".
A similar reclassification has a positive impact on "Net cash inflow from operating activities" with a corresponding negative impact in "Effects of exchange rate changes on cash and cash equivalents" of kEUR 7,360 for Q1 2025 and kEUR 15,858 for H1 2025. The comparative numbers for comparable periods in 2024 are not material. Overall, there is no change in "cash and cash equivalents" and "total changes in cash and cash equivalents" in the statement of cash flows for Q1 2025 and H1 2025.
Significant transactions with related parties in accordance with section 115 (4) sentence 2 WpHG and IAS 34.15B (j)
With the addition of 3 new supervisory board members during Annual General Meeting ('AGM') held on June 30, 2025, the total number of colleagues who were a part of key management as on September 30, 2025 were 10 (December 31, 2024: 7). Further, there are no significant changes in transactions with the related parties.
As the amount in the transactions with related parties is not material, the same has not been disclosed in these interim financial statements.
Basis of consolidation
These interim financial statements as at September 30, 2025 include all the subsidiaries of the Group as mentioned in the consolidated financial statements as at December 31, 2024 along with the following additions made during the first nine months of 2025**:**
- (i) Nagarro AI Limited, United Arab Emirates
- (ii) Nagarro LLC, Kazakhstan
The following entities were closed during the first nine months of 2025:
- (i) Tech Mills (Australia) Pty Ltd., Australia
- (ii) Nagarro Software FZCO, United Arab Emirates
Also to improve operational alignment, Nagarro has merged the following legal entities:
(i) Nagarro Software, S.L., Spain has been merged with Advanced Programming Solutions, S.L., Spain with an effective merger date of January 1, 2025.
{25}------------------------------------------------

(ii) Nagarro has merged Nagarro ATCS GmbH, Germany, with Nagarro GmbH, Germany, legally effective as of August 7, 2025 and for accounting purposes as of January 2, 2025.
Further, by way of business transfer agreement, Nagarro has acquired certain assets and assumed certain liabilities in the following entities:
- (i) Notion Edge France SAS, France, through Nagarro ES France SAS, France, amounting to kEUR 300
- (ii) The Marlo Group Pty Ltd., Australia, through Nagarro Pty. Ltd., Australia, amounting to kEUR 507 (kAUD 900)
Events after the balance sheet date
There are no significant developments between September 30, 2025 and the approval of the report by the Management Board on November 13, 2025, for publication.
{26}------------------------------------------------


{27}------------------------------------------------
Financial calendar
For details, refer our IR website:
Imprint
Nagarro SE Baierbrunner Str. 15 81379 Munich Germany
Phone: +49 89 785 000 282
+49 89 231 219 151 (Investor Relations)
Fax: +49 32 222 132 620 E-Mail: [email protected]
[email protected] (Investor Relations)
Authorized representatives Management Board:
Manas Human (Chairperson), Annette Mainka, Vikram Sehgal
Chairperson of the Supervisory Board:
Dr. Martin Enderle
Registration Court:
HRB-Nr. 254410, Amtsgericht München
VAT ID:
DE 815882160
Contentwise responsible person in accordance with § 18 paragraph 2 MStV:
Manas Human (address like above)
Investor Relations:
Michael Knapp